A lipid profile is one of the most important blood tests for long term cardiovascular health. But most patients receive their report with only a brief explanation of whether the numbers are in range. Understanding what each value means and which numbers actually predict cardiovascular events is essential, especially for Indians who have a genetically higher cardiovascular risk at lower BMI than Western populations.
This guide walks through every component of a standard lipid profile, advanced lipid testing, interpretation by risk category, and what to do with an abnormal result.
What is in a standard lipid profile
A basic lipid profile measures four values:
- Total cholesterol
- Low density lipoprotein (LDL) cholesterol
- High density lipoprotein (HDL) cholesterol
- Triglycerides
Additional values calculated from these include non HDL cholesterol and cholesterol to HDL ratio. More comprehensive panels include Apolipoprotein B (ApoB), Apolipoprotein A1 (ApoA1), and Lipoprotein(a) (Lp(a)).
Understanding each value
Total cholesterol
Normal: Below 200 mg per dL. Borderline high: 200 to 239 mg per dL. High: 240 mg per dL or above. This is the sum of all cholesterol in the blood. It is a crude marker because it does not distinguish between protective HDL and atherogenic LDL. Modern practice focuses more on LDL and ApoB than total cholesterol.
LDL cholesterol (bad cholesterol)
LDL transports cholesterol from liver to tissues and deposits it in artery walls. Elevated LDL is the most well established cardiovascular risk factor among lipid parameters.
LDL targets vary by cardiovascular risk category:
- Low risk (healthy adults): Below 130 mg per dL acceptable, below 100 is better
- Moderate risk (1 to 2 risk factors): Below 130 mg per dL
- High risk (diabetes, family history CHD): Below 100 mg per dL
- Very high risk (established heart disease): Below 70 mg per dL, ideally below 55
- Extreme risk (multiple ASCVD events): Below 40 mg per dL
These targets have tightened over the past decade as evidence for aggressive LDL lowering has strengthened. The mantra is now lower is better, with no clear lower threshold of benefit in high risk patients.
HDL cholesterol (good cholesterol)
HDL transports cholesterol from tissues back to the liver for excretion. Higher HDL was historically considered protective, but recent research has tempered this simple view.
Standard thresholds:
- Men: Below 40 mg per dL is low, above 60 is optimal
- Women: Below 50 mg per dL is low, above 60 is optimal
Recent data suggests that very high HDL (above 80 to 100) may not confer additional benefit and may actually mark dysfunction of HDL particles. The quality and functionality of HDL may matter more than the quantity.
Triglycerides
Triglycerides are fats stored in adipose tissue and circulating in blood. Elevated triglycerides are associated with insulin resistance, metabolic syndrome, and cardiovascular risk.
- Normal: Below 150 mg per dL
- Borderline high: 150 to 199 mg per dL
- High: 200 to 499 mg per dL
- Very high: 500 mg per dL or above (pancreatitis risk)
Fasting triglycerides are the standard measurement. Triglycerides rise significantly after meals, so a 10 to 12 hour fast is required for accurate measurement.
Calculated values and ratios
Non HDL cholesterol
Calculated as Total Cholesterol minus HDL. Represents all atherogenic cholesterol (LDL plus VLDL plus IDL). Target is generally 30 mg per dL above the corresponding LDL target.
Cholesterol to HDL ratio
Target below 4 for low risk, below 3 ideally. A ratio of 3 means your HDL is one third of your total cholesterol. Higher ratios suggest more atherogenic particles relative to protective particles.
Triglyceride to HDL ratio
A marker of insulin resistance and small dense LDL particles. Target below 3. A ratio above 3.5 strongly suggests metabolic syndrome and is associated with cardiovascular risk.
Advanced lipid testing
Apolipoprotein B (ApoB)
Each LDL, VLDL, and Lp(a) particle has one ApoB molecule. ApoB count therefore represents the number of atherogenic particles in circulation. For patients with high triglycerides, diabetes, or metabolic syndrome, ApoB is often a more accurate risk marker than LDL cholesterol.
Target ApoB:
- Low risk: Below 100 mg per dL
- High risk: Below 80 mg per dL
- Very high risk: Below 65 mg per dL
Lipoprotein(a) or Lp(a)
A genetically determined particle similar to LDL but with an additional protein (apolipoprotein(a)). Elevated Lp(a) is an independent cardiovascular risk factor affecting 20 to 25 percent of the population. Levels are stable throughout life and only minimally responsive to lifestyle.
Target: Below 30 mg per dL (below 75 nmol per L). Levels above 50 mg per dL significantly increase cardiovascular risk. Should be measured once in adulthood, especially in patients with family history of premature cardiovascular disease.
Small dense LDL particles
Not all LDL is equally dangerous. Small dense LDL particles are more atherogenic than large buoyant particles. Some labs offer LDL particle size analysis. This is most useful in patients with mixed dyslipidemia or metabolic syndrome.
When fasting matters
For decades, fasting was required before lipid testing. Current guidelines have relaxed this requirement for most situations because triglyceride elevation from food is usually modest.
- Screening in healthy adults: Non fasting is acceptable
- Diagnosis of hypertriglyceridemia: Fasting required
- Monitoring treatment: Non fasting acceptable if previously done non fasting
- Calculating LDL by Friedewald formula: Fasting recommended
Indian specific considerations
Indians have a well documented tendency toward:
- Higher triglycerides and lower HDL at any given BMI
- Higher small dense LDL particle fraction
- Earlier cardiovascular disease (on average 10 years earlier than Western populations)
- Higher Lp(a) levels
- Higher cardiovascular risk at lower BMI thresholds
The Indian Association of Clinical Cardiology recommends more aggressive lipid management for Indian patients, especially those with family history of premature coronary artery disease.
Lifestyle interventions
The most effective non pharmacological interventions for dyslipidemia are:
- Mediterranean or DASH dietary pattern showing consistent 5 to 15 percent LDL reductions
- Soluble fiber intake of 10 to 25 grams daily reducing LDL by 5 to 10 percent
- Plant sterols and stanols 2 grams daily reducing LDL by 6 to 10 percent
- Regular aerobic exercise improving HDL by 5 to 10 percent and reducing triglycerides
- Weight loss reducing LDL by 2 to 3 mg per dL per kg lost
- Smoking cessation improving HDL within weeks to months
- Alcohol moderation or elimination reducing triglycerides significantly
When medications are needed
Statin therapy is indicated for:
- Established atherosclerotic cardiovascular disease
- LDL 190 mg per dL or above (familial hypercholesterolemia)
- Diabetes age 40 to 75 with LDL 70 mg per dL or above
- Ten year cardiovascular risk above 7.5 percent with risk factors
Common statin choices in India include Atorvastatin (generic widely available, Rs. 50 to Rs. 300 per month), Rosuvastatin, and Simvastatin. Side effects are typically mild but myalgia affects 5 to 10 percent of users.
For patients with high triglycerides not responding to statins, options include:
- Fibrates (fenofibrate 145 mg daily)
- Prescription omega 3 (EPA and DHA 4 grams daily)
- Niacin (less used now due to side effects)
Newer options for high risk patients include PCSK9 inhibitors (alirocumab, evolocumab) and inclisiran, though cost remains significant.
Bottom line
Your lipid profile tells more than just whether your cholesterol is high. Read it in context of your overall cardiovascular risk, family history, diabetes status, and age. For Indian patients especially, aggressive lipid management pays off over decades. Ask your doctor about ApoB and Lp(a) testing if you have any cardiovascular risk factors or family history of early heart disease.